| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/28/2007 | CN1935840A Human receptor proteins; related reagents and methods |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1307195C High level expression of proteins |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/27/2007 | US7197400 System and computer software products for comparative gene expression analysis |
| 03/27/2007 | US7196243 Nucleic acids; determination of immunosuppressant |
| 03/27/2007 | US7196187 Method for producing antibody fragments |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196177 regulator controlling inflammatory cytokines in rheumatoid athritis |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide |
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7195926 preparing polyclonal antibodies by immunizing animals with polypeptides under conditions to elicit an antibody response and screening the resultant antigens with the polypeptide to identifying polyclonal antibodies which bind specifically to the polypeptide |
| 03/27/2007 | US7195915 Vectors for animal cells and use thereof |
| 03/27/2007 | US7195904 Preparing hydroxynitrilase for generation of cyanohydrins; disease resistant plants |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195901 nucleotide sequence that code for polypeptides having transferase enzyme activity, used to transform plants and microorganisms, and and shows selective action for hydroxylated fatty acyl glycerides; castor oil biosynthesis with by-product inhibition |
| 03/27/2007 | US7195900 Comprises enzymatic polypeptide with amino acid oxidase activity for preparation of chemical intermediates for antibiotics and hypotensive agents |
| 03/27/2007 | US7195897 Feedback-resistant homoserine transsuccinylases having a modified c-terminus |
| 03/27/2007 | US7195895 Amplifying nucleotide sequences and using produts for in vitro translation; structural genomics |
| 03/27/2007 | US7195893 Nucleic acids encoding α2δ calcium channel subunits and methods for making and using them |
| 03/27/2007 | US7195892 Acylase gene |
| 03/27/2007 | US7195889 Mixing salt of tris(m-sulfonatophenyl)phosphine with oxidoreductases and reducing with hydrogen |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/27/2007 | US7195764 Cancerous disease modifying antibodies |
| 03/27/2007 | US7195762 Density enhanced protein tyrosine phosphatases |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2191583C Methods and compositions for modulating morphogenic protein expression |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/27/2007 | CA2084552C Novel synthetic isohirudins with improved stability |
| 03/22/2007 | WO2007032560A1 Novel monoclonal antibody and use thereof |
| 03/22/2007 | WO2007032559A1 Novel monoclonal antibody and use thereof |
| 03/22/2007 | WO2007032490A1 Process for producing thioredoxin |
| 03/22/2007 | WO2007032241A1 Microparticle-protein complex, method for production of the complex, semiconductor device, and fluorescent labeling method |
| 03/22/2007 | WO2007032160A1 Marker gene for examining hypertension |
| 03/22/2007 | WO2007014455A9 Cancerous disease modifying antibodies |
| 03/22/2007 | WO2006125821A3 Scalable fermentation process |
| 03/22/2007 | WO2006113959A3 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 03/22/2007 | WO2006066214A3 Use of flagellin in the immunotherapy of yersinia pestis |
| 03/22/2007 | WO2006058225A3 Enzymatic reactions in the presence of keto acids |
| 03/22/2007 | WO2006020581A3 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 03/22/2007 | US20070067858 Novel il-8-like polypeptides |
| 03/22/2007 | US20070067857 Therapeutic agent for NGF |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070067855 Production of human glycosylated proteins in transgenic insects |
| 03/22/2007 | US20070067854 Chimeric mouse having an immune system constructed with human CD34+ cells and use thereof |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066811 Adipocyte complement related protein zacrp3x2 |
| 03/22/2007 | US20070066808 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066807 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066802 Chimeric receptors with disrupted dileucine motifs |
| 03/22/2007 | US20070066801 Identification of reagents for the diagnosis and study of francisella |
| 03/22/2007 | US20070066800 Apo2l(trail) receptor binding peptides and uses thereof |
| 03/22/2007 | US20070066565 Cyclic maltosylmatose |
| 03/22/2007 | US20070066531 Enhanced membrane binding affinityl blood coagulation |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066520 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 03/22/2007 | US20070066515 Novel glycoprotein and pharmaceutical composition containing the same |
| 03/22/2007 | US20070065928 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids |
| 03/22/2007 | US20070065919 produces anti-Staphylococcus antibodies; monoclonal antibody is produced by providing a population of B-lymphocytes from a donor, immortalizing the population, separating a plurality of cells from the population to yield a first oligoclonal cell culture, culturing the the cell culture; |
| 03/22/2007 | US20070065918 Purified mammalian cytokines; related reagents and methods |
| 03/22/2007 | US20070065917 Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions |
| 03/22/2007 | US20070065916 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065914 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/22/2007 | US20070065913 Isolation of binding proteins with high affinity to ligands |
| 03/22/2007 | US20070065912 Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis |
| 03/22/2007 | US20070065911 kits; immunoassay for virus detection; vaccination; New isolates of HCV has been characterized from different parts of the world |
| 03/22/2007 | US20070065910 bacterium or yeast cells genetically engineered to express mutated chorismate mutase/prephenate dehydrogenase, used in the production of tyrosine-enriched foods or nutraceuticals |
| 03/22/2007 | US20070065909 Prokaryotically produced antibodies and uses thereof |
| 03/22/2007 | US20070065907 Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 03/22/2007 | US20070065906 Process for producing heterologous protein in e. coli |
| 03/22/2007 | US20070065905 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 03/22/2007 | US20070065903 Process for chromosomal expression of foreign genes in the hsdM region of a methylotrophic microbial host cell |
| 03/22/2007 | US20070065897 Human PRSS11-like S2 serine protease and uses thereof |
| 03/22/2007 | US20070065890 Method for promoting formation of facultative heterochromatin |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065852 HIV recombinant vaccine |
| 03/22/2007 | US20070065849 Nucleic acid encoding eosinophil eotaxin receptor |
| 03/22/2007 | US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 03/22/2007 | US20070065831 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS) |
| 03/22/2007 | US20070065820 Lipid-associated molecules |
| 03/22/2007 | US20070065819 Novel fprl1 ligands and use thereof |
| 03/22/2007 | US20070065818 encoded by an isolated nucleic acid; a culture product; bioassay for determining the intracellular calcium concentration; immunoassay; bioluminescence resonance energy transfer (BRET) system |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065446 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer |